AC Immune SA is clinical-stage biopharmaceutical company that aims to become a global leader in precision medicine for neurodegenerative diseases, including Alzheimer’s disease, Parkinson’s disease, and NeuroOrphan indications driven by misfolded proteins. The Company’s two clinically validated technology platforms, SupraAntigen™ and Morphomer™, fuel its broad and diversified pipeline of first- and best-in-class assets, which currently features nine therapeutic and three diagnostic candidates, six of which are currently in clinical trials. AC Immune has a strong track record of securing strategic partnerships with leading global pharmaceutical companies including Genentech, a member of the Roche Group, Eli Lilly and Company, and Janssen Pharmaceuticals, Inc., resulting in substantial non-dilutive funding to advance its proprietary programs and >$3 billion in potential milestone payments.
View Top Employees from AC Immune| Website | http://www.acimmune.com |
| Ticker | ACIU |
| Revenue | $7 million |
| Funding | $66 million |
| Employees | 171 (168 on RocketReach) |
| Founded | 2003 |
| Address | EPFL Innovation Park Building B, Lausanne, Vaud 1015, CH |
| Phone | +41 21 345 91 21 |
| Fax | +41 21 345 91 20 |
| Technologies |
JavaScript,
HTML,
PHP
+26 more
(view full list)
|
| Industry | Biotechnology Research, Drug Manufacturing & Research, Biotechnology, Therapeutics and diagnostics neurodegenerative diseases, Pharmaceuticals, Science and Engineering, Alzheimer's disease, Healthcare, Pharmaceutical, Health Care, Therapeutics |
| Web Rank | 8 Million |
| Keywords | Ac Immune Sa, Ac Immune, Geneva Pharma, Ac Immune Sa F-1 Filing Date, Ac Immune Stock |
| Competitors | Ardelyx, Inc., G1 Therapeutics, Inc., Otonomy, Inc, Visterra Inc., Xenon Pharmaceuticals Inc. |
| SIC | SIC Code 283 Companies, SIC Code 28 Companies |
| NAICS | NAICS Code 3254 Companies, NAICS Code 325 Companies, NAICS Code 32541 Companies, NAICS Code 32 Companies, NAICS Code 325414 Companies |
Looking for a particular AC Immune employee's phone or email?
AC Immune Questions
The AC Immune annual revenue was $7 million in 2024.
Marie Kosco-Vilbois is the Chief Scientific Officer of AC Immune.
168 people are employed at AC Immune.
AC Immune is based in Lausanne, Vaud.
The NAICS codes for AC Immune are [3254, 325, 32541, 32, 325414].
The SIC codes for AC Immune are [283, 28].
Top AC Immune Employees
-
14
-
2
-
23
-
13
-
45+
-
1
-
2
-
23
Related Companies
